Status:
COMPLETED
Spy II Clinical Registry
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Biliary Tract Diseases
Eligibility:
All Genders
18+ years
Brief Summary
A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
Eligibility Criteria
Inclusion
- Male or female \>= 18 years of age
- Willing and able to comply with the Registry procedures and provide written informed consent to participate in the Registry
- Indicated for ERCP or ERCP/cholangioscopy (with or without biopsy)
Exclusion
- Subjects for whom endoscopic procedure are medically contraindicated
- Subjects for whom ERCP are medically contraindicated
- Subjects for whom medical condition warrants use of device outside of indication for use
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
297 Patients enrolled
Trial Details
Trial ID
NCT00751998
Start Date
November 1 2006
End Date
October 1 2009
Last Update
August 19 2021
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
California Pacific Medical Center
San Francisco, California, United States, 94120
2
University of Colorado Hospital
Aurora, Colorado, United States, 80045
3
Indiana University Medical Center
Indianapolis, Indiana, United States, 46202-5253
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215